Unit

UNIT 5.4 Models of Inflammation: Carrageenan- or Complete Freund's Adjuvant (CFA)–Induced Edema and Hypersensitivity in the Rat

  1. Jill C. Fehrenbacher,
  2. Michael R. Vasko,
  3. Djane B. Duarte

Published Online: 1 MAR 2012

DOI: 10.1002/0471141755.ph0504s56

Current Protocols in Pharmacology

Current Protocols in Pharmacology

How to Cite

Fehrenbacher, J. C., Vasko, M. R. and Duarte, D. B. 2012. Models of Inflammation: Carrageenan- or Complete Freund's Adjuvant (CFA)–Induced Edema and Hypersensitivity in the Rat. Current Protocols in Pharmacology. 56:5.4:5.4.1–5.4.4.

Author Information

  1. Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana

Publication History

  1. Published Online: 1 MAR 2012
  2. Published Print: MAR 2012

This is not the most recent version of the article. View current version (1 SEP 2015)

Abstract

Animal models of inflammation are used to assess the production of inflammatory mediators at sites of inflammation, the anti-inflammatory properties of agents such as nonsteroidal anti-inflammatory drugs (NSAIDs), and the efficacy of putative analgesic compounds in reversing cutaneous hypersensitivity. This unit details methods to elicit and measure carrageenan- and complete Freund's adjuvant (CFA)–induced cutaneous inflammation. Due to possible differences between the dorsal root sensory system and the trigeminal sensory system, injections of either the footpad or vibrissal pad are described. In this manner, cutaneous inflammation can be assessed in tissue innervated by the lumbar dorsal root ganglion neurons (footpad) and by the trigeminal ganglion neurons (vibrissal pad). Curr. Protoc. Pharmacol. 56:5.4.1-5.4.7. © 2012 by John Wiley & Sons, Inc.

Keywords:

  • inflammation;
  • carrageenan;
  • complete Freund's adjuvant;
  • edema;
  • nociception